Regarding "Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients" [2] (multiple letters)

Journal of Vascular Surgery

Volumn 37, Issue 3, 2003, Pages 700-701

  Paramo, Juan Carlos ^a   Sendzischew, Harry ^a   Sivina, Manuel ^a   Hingorani, Anil ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTERY INTIMA PROLIFERATION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HEMATOMA; HEPARINIZATION; HOSPITALIZATION; HUMAN; LETTER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS; VASCULAR SURGERY;

EID: 0037345969     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2003.134     Document Type: Letter

References (5)

1. A Hingorani C Gramse E. Ascher Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients J Vasc Surg 36 2002 341 345
2. JC Paramo H Sendzischew M. Sivina Comparison of the use of enoxaparin versus unfractionated heparin in patients undergoing lower extremity revascularization Vasc Endovasc Surg 36 2002 199 205
3. J Hirsch TE Warkentin R Raschke Heparin and low-molecular-weight heparin Chest 114 suppl 1998 s489 s510
4. L Bara E Billaud G Gramond Comparative phamacokinetics of low molecular weight heparin and unfractionated heparin after intravenous and subcutaneous administration Thromb Res 39 1985 631 636
5. TE Wankentin MN Levine J Hirsh Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin N Engl J Med 332 1995 1330 1335